TOKYO, Aug. 4, 2026 /PRNewswire/ -- TIER IV, the pioneering force behind open-source software for autonomous driving, has signed a memorandum of understanding (MoU) with Astemo, to jointly develop a next-generation software development platform for autonomous driving systems. Through this...
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of all persons or entities who held DNOW Inc. (NYSE: DNOW) common stock as of the August 5, 2025 record date and were thus entitled to...
SAN CARLOS, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia”) (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced the pricing of its upsized initial public offering of 17,000,000 shares of its common stock at an initial public offering price of $17.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $289.0 million. All shares of common stock to be sold in the offering will be sold by Attovia. In addition, Attovia has granted the underwriters a 30-day option to purchase up to an additional 2,550,000 shares of common stock at the initial public
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 4, 2026 /WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE:BTU) between October 14, 2024 to May 4, 2026, inclusive (the "Class Period"), of the important August 24, 2026 lead plaintiff deadline. SO WHAT: If you purchased Peabody Energy common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Peabody Energy class action, go to https://rosenlegal.com/cases/peabody-energy-corporation/join or call ..
Conçue spécialement pour tirer complètement parti de toute la puissance des données exclusives de Lockton, de ses analyses avancées, de ses capacités basées sur l'IA et de son expertise spécialisée, afin d'accompagner la prise de décision des clients KANSAS CITY, Missouri, 5 août 2026...
Madison Seating reports rising customer interest in Steelcase office chair models with adjustable lumbar support, citing broader ergonomic workplace design trends.
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired First Solar, Inc. (NASDAQ:FSLR) securities. If you suffered a loss on your First Solar, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about First Solar, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 4, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Peabody Energy Corporation (NYSE:BTU) securities. If you suffered a loss on your Peabody Energy investment and would like to explore a potential recovery under the federal securities laws, Learn about Peabody Energy Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Peabody ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 4, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Capricor Therapeutics, Inc. ("Capricor Therapeutics, Inc.") (NASDAQ:CAPR) concerning potential violations of the federal securities laws. Capricor Therapeutics, Inc. shareholders were hit with a 60% to 70% drop on July 27, 2026, after FDA briefing documents for Deramiocel raised significant concerns with cardiac efficacy and a post-randomization statistical analysis plan change. The FDA briefing documents were released ahead of the July 29, 2026 advisory committee meeting. FDA staff stated that Deramiocel had not demonstrated sufficient effectiveness on the cardiac ..
The updated platform brings protocol design, data capture, biostatistics, clinical operations monitoring, medical writing and multi-region regulatory support into a single AI-enabled clinical research offering.
New mobile voice changer combines an integrated microphone, USB-C plug-and-play connectivity and access to more than 500 AI voices in a portable wired design.
MOBILE, Ala., Aug. 4, 2026 /PRNewswire/ -- Accordia Health is proud to join community health centers nationwide in celebrating National Health Center Week (August 3-9), recognizing the vital role health centers play in providing high-quality, affordable healthcare to Alabama communities....